ReP USP - Resultado da busca

Artigo de periodico
Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma (2023)
Magalhaes, Taciani de Almeida; Cruzeiro, Gustavo Alencastro Veiga; Sousa, Graziella Ribeiro de; Saggioro, Fabiano Pinto ; Marie, Suely Kazue Nagahashi ; Shinjo, Sueli Mieko Oba ; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Fonte: Neuro-oncology. Unidades: FM, FMRP
Assuntos: MEDULOBLASTOMA, NEOPLASIAS DE CABEÇA E PESCOÇO, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHAES, Taciani de Almeida et al. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma. Neuro-oncology, v. 25, n. 1, p. 185-198, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52983. Acesso em: 22 out. 2025.
APA
Magalhaes, T. de A., Cruzeiro, G. A. V., Sousa, G. R. de, Saggioro, F. P., Marie, S. K. N., Shinjo, S. M. O., et al. (2023). Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma. Neuro-oncology, 25( 1), 185-198. doi:10.1093/neuonc/noac147
NLM
Magalhaes T de A, Cruzeiro GAV, Sousa GR de, Saggioro FP, Marie SKN, Shinjo SMO, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma [Internet]. Neuro-oncology. 2023 ; 25( 1): 185-198.[citado 2025 out. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52983
Vancouver
Magalhaes T de A, Cruzeiro GAV, Sousa GR de, Saggioro FP, Marie SKN, Shinjo SMO, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma [Internet]. Neuro-oncology. 2023 ; 25( 1): 185-198.[citado 2025 out. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52983
Trabalho de evento-resumo periodico
Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning (2019)
Snyder, James; Wells, Michael; Poisson, Laila; Kalkanis, Steven; Noushmehr, Houtan ; Robin, Adam
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: ENSAIO CLÍNICO, MENINGIOMA, GLÂNDULA PITUITÁRIA, NEOPLASIAS CEREBRAIS, ASTROCITOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SNYDER, James et al. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.558. Acesso em: 22 out. 2025. , 2019
APA
Snyder, J., Wells, M., Poisson, L., Kalkanis, S., Noushmehr, H., & Robin, A. (2019). Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.558
NLM
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Vancouver
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Trabalho de evento-resumo periodico
Active transcription start sites of meningioma samples associated with risk of recurrence (2019)
Malta, Tathiane; Sabedot, Thais Sarra; Carlotti Júnior, Carlos Gilberto ; Noushmehr, Houtan
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: TRANSCRIÇÃO GÊNICA, MENINGIOMA, NEOPLASIAS CEREBRAIS, EPIGÊNESE GENÉTICA, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane et al. Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.460. Acesso em: 22 out. 2025. , 2019
APA
Malta, T., Sabedot, T. S., Carlotti Júnior, C. G., & Noushmehr, H. (2019). Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.460
NLM
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Vancouver
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Trabalho de evento-resumo periodico
Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs (2019)
Berezovsky, Artem; Nuga, Oluwademilade; Meng, Yuling; Poisson, Laila; Noushmehr, Houtan ; Carvalho, Ana de
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, EXPRESSÃO GÊNICA, REGULAÇÃO GÊNICA, LINHAGEM CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEREZOVSKY, Artem et al. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.457. Acesso em: 22 out. 2025. , 2019
APA
Berezovsky, A., Nuga, O., Meng, Y., Poisson, L., Noushmehr, H., & Carvalho, A. de. (2019). Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.457
NLM
Berezovsky A, Nuga O, Meng Y, Poisson L, Noushmehr H, Carvalho A de. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs [Internet]. Neuro-oncology. 2019 ; 21 vi109.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.457
Vancouver
Berezovsky A, Nuga O, Meng Y, Poisson L, Noushmehr H, Carvalho A de. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs [Internet]. Neuro-oncology. 2019 ; 21 vi109.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.457
Artigo de periodico
Molecular and translational advances in meningiomas (2019)
Suppiah, Suganth; Nassiri, Farshad; Bi, Wenya Linda; Dunn, Ian F.; Hanemann, Clemens Oliver; Horbinski, Craig M.; Hashizume, Rintaro; James, Charles David; Mawrin, Christian; Noushmehr, Houtan
Fonte: Neuro-oncology. Unidade: FMRP
Assuntos: GENÉTICA, LINHAGEM CELULAR, MENINGIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUPPIAH, Suganth et al. Molecular and translational advances in meningiomas. Neuro-oncology, v. 21, p. 4-17, 2019Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noy178. Acesso em: 22 out. 2025.
APA
Suppiah, S., Nassiri, F., Bi, W. L., Dunn, I. F., Hanemann, C. O., Horbinski, C. M., et al. (2019). Molecular and translational advances in meningiomas. Neuro-oncology, 21, 4-17. doi:10.1093/neuonc/noy178
NLM
Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H. Molecular and translational advances in meningiomas [Internet]. Neuro-oncology. 2019 ; 21 4-17.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noy178
Vancouver
Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H. Molecular and translational advances in meningiomas [Internet]. Neuro-oncology. 2019 ; 21 4-17.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noy178
Trabalho de evento-resumo periodico
DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas (2019)
Wells, Michael; Sabedot, Thais Sarraf; Asmaro, Karam; Mosella, Maritza Queiroz Salas ; Malta, Tathiane; Nelson, Kevin; Snyder, James; Carvalho, Ana de; Mukherjee, Abir; Bahn, Arti; Robin, Adam; Rosenblum, Mark; Mikkelsen, Tom; Poisson, Laila; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Rock, Jack; Noushmehr, Houtan ; Chitale, Dhananjay; Castro, Anavaleria
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS, GLÂNDULA PITUITÁRIA, METILAÇÃO DE DNA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELLS, Michael et al. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.426. Acesso em: 22 out. 2025. , 2019
APA
Wells, M., Sabedot, T. S., Asmaro, K., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2019). DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.426
NLM
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Vancouver
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Trabalho de evento-resumo periodico
Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma (2019)
Lee, Ian; Hunt, Rachel; Nelson, Kevin; Patil, Darshana; Datta, Vineet; Akolkar, Dadasaheb; Apurva, Sachin; Fulmali, Pooja; Puranik, Sneha; Snyder, James; Noushmehr, Houtan ; Devhare, Pradeep; Carvalho, Ana de; Datar, Rajan; Walbert, Tobias; Kalkanis, Steven
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, GLIOMA, LEUCEMIA, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEE, Ian et al. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.659. Acesso em: 22 out. 2025. , 2019
APA
Lee, I., Hunt, R., Nelson, K., Patil, D., Datta, V., Akolkar, D., et al. (2019). Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.659
NLM
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Vancouver
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Trabalho de evento-resumo periodico
Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks (2019)
Li, Kay Ka-Wai; Chen, Hong; Noushmehr, Houtan ; Ng, Ho-Keung
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, MUTAÇÃO GENÉTICA, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LI, Kay Ka-Wai et al. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.611. Acesso em: 22 out. 2025. , 2019
APA
Li, K. K. -W., Chen, H., Noushmehr, H., & Ng, H. -K. (2019). Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.611
NLM
Li KK-W, Chen H, Noushmehr H, Ng H-K. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks [Internet]. Neuro-oncology. 2019 ; 21 vi146.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.611
Vancouver
Li KK-W, Chen H, Noushmehr H, Ng H-K. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks [Internet]. Neuro-oncology. 2019 ; 21 vi146.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.611
Artigo de periodico
Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life (2019)
Nassiri, Farshad; Price, Benjamin; Shehab, Ameer; Au, Karolyn; Cusimano, Michael D.; Jenkinson, Michael D.; Jungk, Christinde; Mansouri, Alireza; Santarius, Thomas; Suppiah, Suganth; Noushmehr, Houtan
Fonte: Neuro-oncology. Unidade: FMRP
Assuntos: MENINGIOMA, CIRURGIA, QUALIDADE DE VIDA, INSÔNIA, COGNIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASSIRI, Farshad et al. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life. Neuro-oncology, v. 21, p. 32-43, 2019Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noy152. Acesso em: 22 out. 2025.
APA
Nassiri, F., Price, B., Shehab, A., Au, K., Cusimano, M. D., Jenkinson, M. D., et al. (2019). Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life. Neuro-oncology, 21, 32-43. doi:10.1093/neuonc/noy152
NLM
Nassiri F, Price B, Shehab A, Au K, Cusimano MD, Jenkinson MD, Jungk C, Mansouri A, Santarius T, Suppiah S, Noushmehr H. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life [Internet]. Neuro-oncology. 2019 ; 21 32-43.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noy152
Vancouver
Nassiri F, Price B, Shehab A, Au K, Cusimano MD, Jenkinson MD, Jungk C, Mansouri A, Santarius T, Suppiah S, Noushmehr H. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life [Internet]. Neuro-oncology. 2019 ; 21 32-43.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noy152
Trabalho de evento-resumo periodico
Methylation-based liquid biopsy of meningioma primary and recurrent samples (2019)
Sabedot, Thais Sarraf; Malta, Tathiane; Snyder, James; Walbert, Tobias; Lee, Ian; Kalkanis, Steven; Castro, Anavaleria; Noushmehr, Houtan
Fonte: Neuro-oncology. Nome do evento: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: MENINGIOMA, NEOPLASIAS CEREBRAIS, BIÓPSIA, BIOMARCADORES, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.463. Acesso em: 22 out. 2025. , 2019
APA
Sabedot, T. S., Malta, T., Snyder, J., Walbert, T., Lee, I., Kalkanis, S., et al. (2019). Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.463
NLM
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Vancouver
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Artigo de periodico
Imaging and diagnostic advances for intracranial meningiomas (2019)
Huang, Raymond Y.; Bi, Wenya Linda; Griffith, Brent; Kaufmann, Timothy J.; la Fougère, Christian la; Schmidt, Nils Ole; Tonn, Jöerg C.; Vogelbaum, Michael A.; Wen, Patrick Y.; Aldape, Kenneth; Noushmehr, Houtan
Fonte: Neuro-oncology. Unidade: FMRP
Assuntos: TOMOGRAFIA, MENINGIOMA, RESSONÂNCIA MAGNÉTICA, RADIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUANG, Raymond Y. et al. Imaging and diagnostic advances for intracranial meningiomas. Neuro-oncology, v. 21, p. 44-61, 2019Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noy143. Acesso em: 22 out. 2025.
APA
Huang, R. Y., Bi, W. L., Griffith, B., Kaufmann, T. J., la Fougère, C. la, Schmidt, N. O., et al. (2019). Imaging and diagnostic advances for intracranial meningiomas. Neuro-oncology, 21, 44-61. doi:10.1093/neuonc/noy143
NLM
Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C la, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Noushmehr H. Imaging and diagnostic advances for intracranial meningiomas [Internet]. Neuro-oncology. 2019 ; 21 44-61.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noy143
Vancouver
Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C la, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Noushmehr H. Imaging and diagnostic advances for intracranial meningiomas [Internet]. Neuro-oncology. 2019 ; 21 44-61.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noy143
Artigo de periodico
Advances in multidisciplinary therapy for meningiomas (2019)
Brastianos, Priscilla K.; Galania, Evanthia; Butowski, Nicholas; Chan, Jason W.; Dunn, Ian F.; Goldbrunner, Roland; Herold-Mende, Christel; Ippen, Franziska M.; Mawrin, Christian; Noushmehr, Houtan
Fonte: Neuro-oncology. Unidade: FMRP
Assuntos: ENSAIO CLÍNICO, MENINGIOMA, CIRURGIA, QUIMIOTERAPIA, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASTIANOS, Priscilla K. et al. Advances in multidisciplinary therapy for meningiomas. Neuro-oncology, v. 21, p. 18-31, 2019Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noy136. Acesso em: 22 out. 2025.
APA
Brastianos, P. K., Galania, E., Butowski, N., Chan, J. W., Dunn, I. F., Goldbrunner, R., et al. (2019). Advances in multidisciplinary therapy for meningiomas. Neuro-oncology, 21, 18-31. doi:10.1093/neuonc/noy136
NLM
Brastianos PK, Galania E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, Noushmehr H. Advances in multidisciplinary therapy for meningiomas [Internet]. Neuro-oncology. 2019 ; 21 18-31.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noy136
Vancouver
Brastianos PK, Galania E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, Noushmehr H. Advances in multidisciplinary therapy for meningiomas [Internet]. Neuro-oncology. 2019 ; 21 18-31.[citado 2025 out. 22 ] Available from: https://doi.org/10.1093/neuonc/noy136
Trabalho de evento-resumo periodico
(TC)-T-99M-MIBI Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) to detect tumor progression in Glioblastomas (GB) (2017)
Victor, Carolina; Lopez, Rossana; Nunes, Rafael; Marta, Gustavo; Picarelli, Helder; Buchpiguel, Carlos Alberto; Feher, Olavo
Fonte: Neuro-oncology. Nome do evento: Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS. Unidade: FM
Assuntos: TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE FÓTON ÚNICO, NEOPLASIAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICTOR, Carolina et al. (TC)-T-99M-MIBI Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) to detect tumor progression in Glioblastomas (GB). Neuro-oncology. Cary: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://observatorio.fm.usp.br/handle/OPI/25168. Acesso em: 22 out. 2025. , 2017
APA
Victor, C., Lopez, R., Nunes, R., Marta, G., Picarelli, H., Buchpiguel, C. A., & Feher, O. (2017). (TC)-T-99M-MIBI Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) to detect tumor progression in Glioblastomas (GB). Neuro-oncology. Cary: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25168
NLM
Victor C, Lopez R, Nunes R, Marta G, Picarelli H, Buchpiguel CA, Feher O. (TC)-T-99M-MIBI Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) to detect tumor progression in Glioblastomas (GB) [Internet]. Neuro-oncology. 2017 ; 19 149-149.[citado 2025 out. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25168
Vancouver
Victor C, Lopez R, Nunes R, Marta G, Picarelli H, Buchpiguel CA, Feher O. (TC)-T-99M-MIBI Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) to detect tumor progression in Glioblastomas (GB) [Internet]. Neuro-oncology. 2017 ; 19 149-149.[citado 2025 out. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25168

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos